# Efficacy of Psidii Guava's Extract For COVID-19

> **NCT04810728** · PHASE3 · COMPLETED · sponsor: **Faculty of Medicine Baiturrahmah University** · enrollment: 90 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Extract Psidii guava
- **COMBINATION_PRODUCT:** Standard therapy for Covid-19 patient

## Key facts

- **NCT ID:** NCT04810728
- **Lead sponsor:** Faculty of Medicine Baiturrahmah University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-20
- **Primary completion:** 2020-12-04
- **Final completion:** 2021-01-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810728, "Efficacy of Psidii Guava's Extract For COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04810728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*